Note 13 - Distribution Agreements |
12 Months Ended | ||
---|---|---|---|
Jun. 30, 2020 | |||
Notes to Financial Statements | |||
Significant Agreements Disclosure [Text Block] |
On The agreement was automatically renewed through July 14, 2017, the Company entered into an agreement with a new distributor in Russia that provides for the ability to sell the entire product line in the Russian Federation. The agreement had a one -year initial term with two additional one -year terms which automatically renew unless either party invokes their right to terminate earlier under the provisions of the agreement. July 2020. On September 22, 2020, the Company entered into an agreement with the same distributor. The agreement has a one -year initial term with two additional one -year terms which automatically renew unless either party invoke their right to terminate earlier under the provisions of the agreement. In fiscal year 2020, the Company entered into a three -year agreement with a distributor in India that provides for the ability to sell Cesium-131 brachytherapy seeds in different configurations within India. The Company and the distributor for Italy and Switzerland executed the distribution agreement on August 1, 2016. The agreement has a one -year initial term with two additional one -year terms which automatically renew unless either party invoke their right to terminate earlier under the provisions of the agreement. The agreement expired on August 1, 2019 and was not renewed. As the Company elected to not renew its CE mark in fiscal 2019, distribution will be limited to those countries outside the European Union. |